Chutianpai Biotechnology (Changsha) Co., Ltd. made its debut at the 2024 China Peptide Drug Innovation Conference

Promoting the innovative development of peptide drugs, Chutian Pet showcases cutting-edge technological strength

On April 19-20, 2024, the highly anticipated Chengdu Peptide Drug Academic Exchange Conference was grandly held in Chengdu. This conference brought together experts, scholars, relevant departments, association leaders, and business representatives from the field of peptide drugs at home and abroad to discuss the latest research achievements and future development trends of peptide drugs.

As one of the earliest companies in the world to provide peptide synthesis equipment, Chutianpai Biotechnology (Changsha) Co., Ltd. has over 20 years of industry experience and profound accumulation of peptide technology. Relying on Chutian's strong manufacturing and delivery capabilities and industrial equipment technology, we form a strong alliance to meet customers' high demand for customized needs. Multiple mixing methods can be used to meet different customer needs理想Through homogeneous reaction, higher purity can be achieved, and advanced GMP synthesis solutions can be created with technologies such as closed inlet and outlet, online drying, etc. Chutian Pat has now become one of the few companiesGlobal FamousOne of the suppliers of peptide synthesis solutions provided by peptide pharmaceutical companies and top research institutions. As a pharmaceutical instrument manufacturing enterprise, Chutian Patel was invited to participate in this grand event and have in-depth exchanges with industry colleagues to jointly promote the innovation and development of the peptide drug industry.

At the conference, representatives from Chutian Pet enthusiastically introduced the exhibited product - peptide synthesizer, which can synchronize multiple projects in one machine and greatly improve users' work efficiency. The participation of Chutianpai not only adds highlights to the 2024 China Peptide Drug Innovation Conference, but also provides new impetus and ideas for promoting the innovative development of peptide drugs in China and even globally. Through this conference, Chutianpai has further consolidated its advantages in the field of peptide synthesis equipmentStatus has been established, and more extensive communication and cooperation have been established with experts, scholars, and enterprises inside and outside the industry.

Peptide synthesis technology is a key foundational technology in the fields of biomedicine and life sciences. Chutian Pet adheres to the development concept of innovation driven and is committed to continuously launching more high-quality products and services through technological innovation to meet the growing market demand. As a key link in the Chu Tian biopharmaceutical and life science industry chain, Chu Tian Pai will continue to shoulder the responsibility of buildingWorld One*The mission of peptide synthesis solutions is to contribute to the development of the global peptide drug market.